Ra Medical Systems to Report 2021 Fourth Quarter and Full Year Financial Results on March 23, 2022
15 Mars 2022 - 9:05PM
Business Wire
Ra Medical Systems, Inc. (NYSE American: RMED) announces that it
will report 2021 fourth quarter and full year financial results
after market close on Wednesday, March 23. Ra Medical management
will hold an investment community conference call that day at 1:30
p.m. Pacific time (4:30 p.m. Eastern time) to discuss financial
results and provide a company update.
Pre-Registration
Participants can pre-register for the
conference call here
Callers who pre-register will be given a
conference passcode and unique PIN to gain immediate access to the
call and bypass the live operator. Participants may pre-register at
any time, including up to and after the call start time.
Live Call:
Those who choose not to pre-register can
access the live conference by dialing:
U.S.
866-777-2509
International
412-317-5413
Request to join the Ra Medical Systems
conference call
Live Webcast:
Ra Medical Systems Website
The webcast will be archived for 30
days.
Replay:
U.S.
877-344-7529
Canada
855-669-9658
International
412-317-0088
Passcode
9255498
The replay will be available for 48
hours
About Ra Medical Systems
Ra Medical Systems manufactures the DABRA excimer laser and
catheters for the treatment of certain vascular diseases. DABRA has
been cleared by the FDA for crossing chronic total occlusions in
patients with symptomatic infrainguinal lower extremity vascular
disease and has an intended use for ablating a channel in occlusive
peripheral vascular disease. In addition, DABRA has been granted CE
mark clearance for the endovascular treatment of infrainguinal
arteries via atherectomy and for crossing total occlusions. DABRA
excimer lasers and catheters are manufactured in a
32,000-square-foot facility located in Carlsbad, California. The
vertically integrated facility is ISO 13485 certified and is
licensed by the State of California to manufacture sterile,
single-use catheters in clean room environments.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220315006115/en/
At the Company: Andrew Jackson Chief Financial Officer,
Ra Medical Systems 760-496-9540 ajackson@ramed.com
Investors: LHA Investor Relations Jody Cain 310-691-7100
jcain@lhai.com
Ra Medical Systems (AMEX:RMED)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Ra Medical Systems (AMEX:RMED)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024